CY1107965T1 - Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος - Google Patents
Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδοςInfo
- Publication number
- CY1107965T1 CY1107965T1 CY20081100542T CY081100542T CY1107965T1 CY 1107965 T1 CY1107965 T1 CY 1107965T1 CY 20081100542 T CY20081100542 T CY 20081100542T CY 081100542 T CY081100542 T CY 081100542T CY 1107965 T1 CY1107965 T1 CY 1107965T1
- Authority
- CY
- Cyprus
- Prior art keywords
- preparation
- mistletoe
- iii
- mistletoe lectin
- oral testing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Ένα παρασκεύασμα για λήψη από το στόμα το οποίο αποτελείται βασικά από λεκτίνη I Ιξού (ML-I), λεκτίνη II Ιξού (ML-II) και λεκτίνη III Ιξού (ML-III), το οποίο ειδικότερα αποκλείει τις ενώσεις οι οποίες προκαλούν ναυτία που υπάρχουν σε εκχυλίσματα ιξού. Η εφεύρεση επίσης παρέχει μια μέθοδο παραγωγής του εν λόγω παρασκευάσματος, μία μέθοδο χρήσης του εν λόγω παρασκευάσματος για την παραγωγή φαρμακευτικών παρασκευασμάτων, και μία μέθοδο για χρήση του εν λόγω παρασκευάσματος στην αγωγή ασθενών οι οποίοι πάσχουν από καρκίνο και αυτοάνοσες νόσους.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24795700P | 2000-11-14 | 2000-11-14 | |
EP01996387A EP1341811B9 (en) | 2000-11-14 | 2001-11-12 | Orally ingestible preparation of mistletoe lectins and method |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107965T1 true CY1107965T1 (el) | 2013-09-04 |
Family
ID=22937047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100542T CY1107965T1 (el) | 2000-11-14 | 2008-05-26 | Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος |
Country Status (13)
Country | Link |
---|---|
US (1) | US7550159B2 (el) |
EP (1) | EP1341811B9 (el) |
JP (1) | JP2004513926A (el) |
KR (1) | KR100832614B1 (el) |
AT (1) | ATE387209T1 (el) |
AU (1) | AU2120502A (el) |
CY (1) | CY1107965T1 (el) |
DE (1) | DE60133036T2 (el) |
DK (1) | DK1341811T3 (el) |
ES (1) | ES2301576T3 (el) |
NZ (1) | NZ526202A (el) |
PT (1) | PT1341811E (el) |
WO (1) | WO2002040041A2 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60220068T2 (de) | 2001-07-09 | 2008-01-24 | University Of Copenhagen | Verfahren und ableger für die massenvermehrung von pflanzenparasiten |
KR101191081B1 (ko) | 2008-05-19 | 2012-10-15 | 김종배 | 운동수행능력 증강 및 피로억제 효과를 갖는 겨우살이추출물 |
RU2644332C1 (ru) * | 2016-12-30 | 2018-02-08 | Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") | Способ получения растительного лектина ml1 из омелы белой и фармацевтическая композиция на его основе (варианты). |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4229876A1 (de) * | 1992-09-04 | 1994-03-10 | Uwe Dr Pfueller | Verfahren zur Gewinnung von Lektinen aus Mistelpflanzen |
DE4242902A1 (de) * | 1992-12-18 | 1994-06-23 | Madaus Ag | Verfahren zur Herstellung von Lektinkonzentraten aus Mistelextrakten und daraus hergestellte standardisierte Präparate zur Erhöhung der natürlichen Immunresistenz und für die Verwendung in der Tumor-Therapie |
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
DE4421895A1 (de) * | 1994-06-23 | 1996-01-04 | Private Uni Witten Herdecke Gm | Verfahren zur Isolierung von Isolektinen aus der Mistel |
AU5532696A (en) * | 1995-04-14 | 1996-10-30 | University Of Southern California | Mistletoe extract and method |
EP0884388A1 (de) * | 1995-06-26 | 1998-12-16 | MADAUS AG Köln | Transgene Pflanzen enthaltend rekombinantes Mistellektin (rML) |
WO1997011967A1 (de) * | 1995-09-27 | 1997-04-03 | Thomas David | Extrakt von viscum album (weisse mistel) |
DE60045516D1 (de) * | 1999-10-26 | 2011-02-24 | Novartis Vaccines & Diagnostic | Pflanzen lektine als mukosale adjuvantien |
-
2001
- 2001-11-12 KR KR1020037006569A patent/KR100832614B1/ko not_active IP Right Cessation
- 2001-11-12 DE DE60133036T patent/DE60133036T2/de not_active Expired - Lifetime
- 2001-11-12 WO PCT/NO2001/000446 patent/WO2002040041A2/en active IP Right Grant
- 2001-11-12 EP EP01996387A patent/EP1341811B9/en not_active Expired - Lifetime
- 2001-11-12 ES ES01996387T patent/ES2301576T3/es not_active Expired - Lifetime
- 2001-11-12 NZ NZ526202A patent/NZ526202A/en not_active IP Right Cessation
- 2001-11-12 AT AT01996387T patent/ATE387209T1/de active
- 2001-11-12 DK DK01996387T patent/DK1341811T3/da active
- 2001-11-12 US US10/416,463 patent/US7550159B2/en not_active Expired - Fee Related
- 2001-11-12 JP JP2002542413A patent/JP2004513926A/ja not_active Ceased
- 2001-11-12 AU AU2120502A patent/AU2120502A/xx not_active Withdrawn
- 2001-11-12 PT PT01996387T patent/PT1341811E/pt unknown
-
2008
- 2008-05-26 CY CY20081100542T patent/CY1107965T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002040041A2 (en) | 2002-05-23 |
JP2004513926A (ja) | 2004-05-13 |
ATE387209T1 (de) | 2008-03-15 |
DK1341811T3 (da) | 2008-06-30 |
WO2002040041A3 (en) | 2002-07-25 |
EP1341811B9 (en) | 2008-11-05 |
EP1341811B1 (en) | 2008-02-27 |
KR20030066664A (ko) | 2003-08-09 |
KR100832614B1 (ko) | 2008-05-27 |
US7550159B2 (en) | 2009-06-23 |
DE60133036D1 (de) | 2008-04-10 |
EP1341811A2 (en) | 2003-09-10 |
NZ526202A (en) | 2005-08-26 |
PT1341811E (pt) | 2008-06-04 |
DE60133036T2 (de) | 2009-04-02 |
ES2301576T3 (es) | 2008-07-01 |
AU2120502A (en) | 2002-05-27 |
US20040052869A1 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0303800A2 (hu) | Gyógyszerkészítmények, adagolási formák epotilonok orális beadására | |
GB0211649D0 (en) | Organic compounds | |
ATE400573T1 (de) | 1h-imidazochinolinderivate als proteinkinaseinhibitoren | |
CY1107838T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
PT1171143E (pt) | Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto | |
WO2002102299A3 (en) | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer | |
HUP0402067A2 (hu) | Oltóanyagok | |
DE60217090D1 (de) | Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel | |
WO2002044324A3 (en) | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | |
NO20064676L (no) | Farmasoytiske salter av 3-0-(3'3'-dimetylsuccinyl)betulinsyre | |
UY27362A1 (es) | Métodos de usar inhibidores de epóxido hidrolasa soluble | |
WO2002040702A3 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
TW200616640A (en) | Novel pharmaceutical formulations of active principles | |
WO2002094774A3 (en) | Oxcarbazepine dosage forms | |
HUP0302874A2 (hu) | Eljárás risperidon előállítására | |
HUP0102913A2 (hu) | Biogén ösztrogén-szulfamátok alkalmazása hormonhelyettesítő terápiánál használható gyógyszerkészítmények előállítására | |
CY1107965T1 (el) | Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος | |
WO2003020214A3 (en) | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | |
MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
CY1107227T1 (el) | Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ | |
DE60233936D1 (de) | Therapeutische Zusammenseztungen zur Toleranzinduktion | |
ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
HUP0301479A2 (hu) | Cilansetron alkalmazása nemobstipációs férfi IBS-betegek kezelésére szolgáló gyógyszerkészítmény elżállítására | |
HUP9801236A2 (hu) | Forskolin vagy ezt tartalmazó extraktum alkalmazása alkoholfüggőség kezelésére alkalmas gyógyszerkészítmény előállítására | |
IL153867A0 (en) | Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma |